T1	CHEM 3 9	Tasmar
#1	AnnotatorNotes T1	C0595276
T2	LIVB 44 51	enfants
#2	AnnotatorNotes T2	C0008059
T3	CHEM 151 160	tolcapone
#3	AnnotatorNotes T3	C0246330
T4	CHEM 178 184	Tasmar
#4	AnnotatorNotes T4	C0595276
T5	CHEM 253 262	comprimés
#5	AnnotatorNotes T5	C0039225
T6	CHEM 266 272	Tasmar
#6	AnnotatorNotes T6	C0595276
T7	CHEM 344 353	tolcapone
#7	AnnotatorNotes T7	C0246330
T8	CHEM 358 364	Tasmar
#8	AnnotatorNotes T8	C0595276
T9	CHEM 396 418	formes pharmaceutiques
#9	AnnotatorNotes T9	C0013058
T10	CHEM 422 430	lévodopa
#10	AnnotatorNotes T10	C0023570
T11	CHEM 433 444	bensérazide
#11	AnnotatorNotes T11	C0005014
T12	CHEM 451 459	lévodopa
#12	AnnotatorNotes T12	C0023570
T13	CHEM 462 471	carbidopa
#13	AnnotatorNotes T13	C0006982
T14	CHEM 500 506	Tasmar
#14	AnnotatorNotes T14	C0595276
T15	LIVB 535 543	patients
#15	AnnotatorNotes T15	C0030705
T16	PROC 562 572	traitement
#16	AnnotatorNotes T16	C0087111
T17	CHEM 577 583	Tasmar
#17	AnnotatorNotes T17	C0595276
T18	LIVB 617 624	médecin
#18	AnnotatorNotes T18	C0031831
T19	PROC 645 655	traitement
#19	AnnotatorNotes T19	C0087111
T20	DISO 662 682	maladie de Parkinson
#20	AnnotatorNotes T20	C0030567
T21	DISO 662 669	maladie
#21	AnnotatorNotes T21	C0012634
T22	CHEM 771 777	Tasmar
#22	AnnotatorNotes T22	C0595276
T23	LIVB 839 846	patient
#23	AnnotatorNotes T23	C0030705
T24	CHEM 901 919	enzymes hépatiques
#24	AnnotatorNotes T24	C0443764
T25	CHEM 901 908	enzymes
#25	AnnotatorNotes T25	C0014442
T26	ANAT 909 919	hépatiques
#26	AnnotatorNotes T26	C0023884
T27	DISO 981 1000	hépatite fulminante
#27	AnnotatorNotes T27	C0302809
T28	DISO 1075 1093	atteinte hépatique
#28	AnnotatorNotes T28	C0151763
T29	ANAT 1084 1093	hépatique
#29	AnnotatorNotes T29	C0023884
T30	CHEM 1094 1108	médicamenteuse
#30	AnnotatorNotes T30	C0013227
T31	CHEM 1141 1151	médicament
#31	AnnotatorNotes T31	C0013227
T32	PROC 1281 1291	traitement
#32	AnnotatorNotes T32	C0087111
T33	CHEM 1296 1302	Tasmar
#33	AnnotatorNotes T33	C0595276
T34	LIVB 1339 1345	femmes
#34	AnnotatorNotes T34	C0015780
T35	DISO 1386 1404	atteinte hépatique
#35	AnnotatorNotes T35	C0151763
T36	ANAT 1395 1404	hépatique
#36	AnnotatorNotes T36	C0023884
T37	PROC 1446 1456	traitement
#37	AnnotatorNotes T37	C0087111
T38	PROC 1466 1495	tests fonctionnels hépatiques
#38	AnnotatorNotes T38	C0023901
T39	ANAT 1485 1495	hépatiques
#39	AnnotatorNotes T39	C0023884
T40	DISO 1523 1529	signes
#40	AnnotatorNotes T40	C0037088
T41	PROC 1545 1555	traitement
#41	AnnotatorNotes T41	C0087111
T42	PHYS 1561 1579	fonction hépatique
#42	AnnotatorNotes T42	C0232741
T43	ANAT 1570 1579	hépatique
#43	AnnotatorNotes T43	C0023884
T44	PROC 1651 1661	traitement
#44	AnnotatorNotes T44	C0087111
T45	PROC 1785 1795	traitement
#45	AnnotatorNotes T45	C0087111
T46	LIVB 1832 1840	patients
#46	AnnotatorNotes T46	C0030705
T47	LIVB 1854 1862	patients
#47	AnnotatorNotes T47	C0030705
T48	DISO 1863 1876	parkinsoniens
#48	AnnotatorNotes T48	C0030567
T49	DISO 1882 1885	SMN
#49	AnnotatorNotes T49	C0027849
T50	CHEM 1942 1953	médicaments
#50	AnnotatorNotes T50	C0013227
T51	CHEM 1976 1991	dopaminergiques
#51	AnnotatorNotes T51	C0013036
T52	DISO 2031 2034	SMN
#52	AnnotatorNotes T52	C0027849
T53	PROC 2057 2067	traitement
#53	AnnotatorNotes T53	C0087111
T54	CHEM 2072 2078	Tasmar
#54	AnnotatorNotes T54	C0595276
T55	DISO 2087 2096	symptômes
#55	AnnotatorNotes T55	C1457887
T56	PROC 2134 2144	traitement
#56	AnnotatorNotes T56	C0087111
T57	CHEM 2149 2155	Tasmar
#57	AnnotatorNotes T57	C0595276
T58	DISO 2209 2219	diagnostic
#58	AnnotatorNotes T58	C0011900
T59	CHEM 2222 2228	Tasmar
#59	AnnotatorNotes T59	C0595276
T60	LIVB 2266 2273	patient
#60	AnnotatorNotes T60	C0030705
T61	CHEM 2328 2336	lévodopa
#61	AnnotatorNotes T61	C0023570
T62	DISO 2383 2402	effets indésirables
#62	AnnotatorNotes T62	C0559546
T63	DISO 2411 2420	diarrhées
#63	AnnotatorNotes T63	C0947873
T64	CHEM 2433 2439	Tasmar
#64	AnnotatorNotes T64	C0595276
T65	PROC 2501 2511	traitement
#65	AnnotatorNotes T65	C0087111
T66	PHYS 2516 2528	Interactions
#66	AnnotatorNotes T66	C0687133
T67	CHEM 2537 2548	bensérazide
#67	AnnotatorNotes T67	C0005014
T68	PHYS 2568 2579	interaction
#68	AnnotatorNotes T68	C0687133
T69	CHEM 2589 2600	bensérazide
#69	AnnotatorNotes T69	C0005014
T70	CHEM 2620 2629	tolcapone
#70	AnnotatorNotes T70	C0246330
T71	CHEM 2689 2700	bensérazide
#71	AnnotatorNotes T71	C0005014
T72	DISO 2777 2796	effets indésirables
#72	AnnotatorNotes T72	C0559546
T73	CHEM 2831 2842	Inhibiteurs
#73	AnnotatorNotes T73	C0003139
T74	CHEM 2849 2852	MAO
#74	AnnotatorNotes T74	C0026454
T75	CHEM 2857 2866	Warfarine
#75	AnnotatorNotes T75	C0043031
T76	CHEM 2936 2945	warfarine
#76	AnnotatorNotes T76	C0043031
T77	CHEM 2952 2961	tolcapone
#77	AnnotatorNotes T77	C0246330
T78	PHYS 2997 3008	coagulation
#78	AnnotatorNotes T78	C0005778
T79	LIVB 3069 3077	patients
#79	AnnotatorNotes T79	C0030705
T80	DISO 3088 3109	maladies héréditaires
#80	AnnotatorNotes T80	C0019247
T81	DISO 3088 3096	maladies
#81	AnnotatorNotes T81	C0012634
T82	DISO 3120 3144	intolérance au galactose
#82	AnnotatorNotes T82	C0865194
T83	CHEM 3161 3168	lactose
#83	AnnotatorNotes T83	C0022949
T84	DISO 3183 3217	malabsorption du glucose-galactose
#84	AnnotatorNotes T84	C0865194
T85	CHEM 3200 3217	glucose-galactose
#85	AnnotatorNotes T85	C0061434
T86	CHEM 3246 3256	médicament
#86	AnnotatorNotes T86	C0013227
T87	CHEM 3261 3267	Tasmar
#87	AnnotatorNotes T87	C0595276
T88	CHEM 3281 3291	inhibiteur
#88	AnnotatorNotes T88	C0003139
T89	CHEM 3298 3302	COMT
#89	AnnotatorNotes T89	C0007407
T90	CHEM 3356 3364	lévodopa
#90	AnnotatorNotes T90	C0023570
T91	DISO 3480 3499	effets indésirables
#91	AnnotatorNotes T91	C0559546
T92	PROC 3551 3561	traitement
#92	AnnotatorNotes T92	C0087111
T93	CHEM 3570 3581	inhibiteurs
#93	AnnotatorNotes T93	C0003139
T94	CHEM 3588 3592	COMT
#94	AnnotatorNotes T94	C0007407
T95	DISO 3623 3642	effets indésirables
#95	AnnotatorNotes T95	C0559546
T96	DISO 3667 3678	dyskinésies
#96	AnnotatorNotes T96	C0013384
T97	DISO 3681 3688	nausées
#97	AnnotatorNotes T97	C0027497
T98	DISO 3691 3703	vomissements
#98	AnnotatorNotes T98	C0042963
T99	DISO 3706 3726	douleurs abdominales
#99	AnnotatorNotes T99	C0000737
T100	DISO 3729 3736	syncope
#100	AnnotatorNotes T100	C0039070
T101	DISO 3753 3762	symptômes
#101	AnnotatorNotes T101	C1457887
T102	DISO 3791 3803	constipation
#102	AnnotatorNotes T102	C0009806
T103	DISO 3806 3825	troubles du sommeil
#103	AnnotatorNotes T103	C0037317
T104	DISO 3828 3838	somnolence
#104	AnnotatorNotes T104	C0013144 C2830004
T106	DISO 3841 3855	hallucinations
#106	AnnotatorNotes T106	C0018524
T107	CHEM 3863 3871	lévodopa
#107	AnnotatorNotes T107	C0023570
T108	DISO 3893 3903	somnolence
#108	AnnotatorNotes T108	C0013144 C2830004
T110	DISO 3913 3929	accès de sommeil
#110	AnnotatorNotes T110	C0027404
T111	DISO 3961 3983	endormissement soudain
#111	AnnotatorNotes T111	C0919582
T112	DISO 4044 4065	signes avant coureurs
#112	AnnotatorNotes T112	C3494358
T113	DISO 4044 4050	signes
#113	AnnotatorNotes T113	C0037088
T114	LIVB 4105 4113	patients
#114	AnnotatorNotes T114	C0030705
T115	OBJC 4230 4239	véhicules
#115	AnnotatorNotes T115	C0175845
T116	OBJC 4262 4270	machines
#116	AnnotatorNotes T116	C0336779
T117	PROC 4282 4292	traitement
#117	AnnotatorNotes T117	C0087111
T118	CHEM 4297 4305	lévodopa
#118	AnnotatorNotes T118	C0023570
T119	CHEM 4352 4360	lévodopa
#119	AnnotatorNotes T119	C0023570
T120	DISO 4367 4386	arrêt du traitement
#120	AnnotatorNotes T120	C1699848
T121	PROC 4376 4386	traitement
#121	AnnotatorNotes T121	C0087111
T122	PHYS 4414 4425	interaction
#122	AnnotatorNotes T122	C0687133
T123	CHEM 4434 4445	bensérazide
#123	AnnotatorNotes T123	C0005014
T124	CHEM 4511 4522	bensérazide
#124	AnnotatorNotes T124	C0005014
T125	CHEM 4533 4543	métabolite
#125	AnnotatorNotes T125	C0002421
T126	ANAT 4573 4585	plasmatiques
#126	AnnotatorNotes T126	C0032105
T127	CHEM 4589 4600	bensérazide
#127	AnnotatorNotes T127	C0005014
T128	CHEM 4641 4650	tolcapone
#128	AnnotatorNotes T128	C0246330
T129	CHEM 4657 4668	bensérazide
#129	AnnotatorNotes T129	C0005014
T130	CHEM 4679 4687	lévodopa
#130	AnnotatorNotes T130	C0023570
T131	DISO 4753 4772	effets indésirables
#131	AnnotatorNotes T131	C0559546
T132	ANAT 4821 4833	plasmatiques
#132	AnnotatorNotes T132	C0032105
T133	CHEM 4841 4852	médicaments
#133	AnnotatorNotes T133	C0013227
T134	CHEM 4879 4885	Tasmar
#134	AnnotatorNotes T134	C0595276
T135	PHYS 4894 4906	interactions
#135	AnnotatorNotes T135	C0687133
T136	CHEM 4957 4967	cytochrome
#136	AnnotatorNotes T136	C1256752
T137	CHEM 4968 4974	CYP2C9
#137	AnnotatorNotes T137	C0608437
T138	CHEM 5007 5018	Médicaments
#138	AnnotatorNotes T138	C0013227
T139	CHEM 5042 5056	catécholamines
#139	AnnotatorNotes T139	C0007412
T140	CHEM 5078 5087	tolcapone
#140	AnnotatorNotes T140	C0246330
T141	DISO 5106 5136	métabolisme des catécholamines
#141	AnnotatorNotes T141	C1156510
T142	CHEM 5122 5136	catécholamines
#142	AnnotatorNotes T142	C0007412
T143	PHYS 5143 5155	interactions
#143	AnnotatorNotes T143	C0687133
T144	DISO 5193 5212	effets indésirables
#144	AnnotatorNotes T144	C0559546
T145	DISO 5243 5262	effets indésirables
#145	AnnotatorNotes T145	C0559546
T146	DISO 5301 5320	effets indésirables
#146	AnnotatorNotes T146	C0559546
T147	CHEM 5417 5428	inhibiteurs
#147	AnnotatorNotes T147	C0003139
T148	CHEM 5451 5464	noradrénaline
#148	AnnotatorNotes T148	C0028351
T149	CHEM 5477 5488	désipramine
#149	AnnotatorNotes T149	C0011685
T150	CHEM 5494 5505	maprotiline
#150	AnnotatorNotes T150	C0024778
T151	LIVB 5547 5555	patients
#151	AnnotatorNotes T151	C0030705
T152	DISO 5571 5591	maladie de Parkinson
#152	AnnotatorNotes T152	C0030567
T153	DISO 5571 5578	maladie
#153	AnnotatorNotes T153	C0012634
T154	PROC 5592 5599	traités
#154	AnnotatorNotes T154	C0087111
T155	CHEM 5604 5610	Tasmar
#155	AnnotatorNotes T155	C0595276
T156	CHEM 5617 5625	lévodopa
#156	AnnotatorNotes T156	C0023570
T157	PHYS 5639 5648	Grossesse
#157	AnnotatorNotes T157	C0032961
T158	LIVB 5659 5662	rat
#158	AnnotatorNotes T158	C0034721
T159	LIVB 5669 5674	lapin
#159	AnnotatorNotes T159	C0178727
T160	CHEM 5731 5737	Tasmar
#160	AnnotatorNotes T160	C0595276
T161	PHYS 5773 5782	grossesse
#161	AnnotatorNotes T161	C0032961
T162	ANAT 5855 5860	fœtus
#162	AnnotatorNotes T162	C0015965
T163	PROC 5869 5885	essais cliniques
#163	AnnotatorNotes T163	C1096775
T164	CHEM 5920 5926	Tasmar
#164	AnnotatorNotes T164	C0595276
T165	OBJC 5971 5979	véhicule
#165	AnnotatorNotes T165	C0175845
T166	OBJC 5998 6005	machine
#166	AnnotatorNotes T166	C0336779
T167	LIVB 6026 6034	patients
#167	AnnotatorNotes T167	C0030705
T168	DISO 6107 6130	symptômes parkinsoniens
#168	AnnotatorNotes T168	C1847652
T169	DISO 6107 6116	symptômes
#169	AnnotatorNotes T169	C1457887
T170	DISO 6139 6158	effets indésirables
#170	AnnotatorNotes T170	C0559546
T171	LIVB 6230 6238	patients
#171	AnnotatorNotes T171	C0030705
T172	PROC 6239 6246	traités
#172	AnnotatorNotes T172	C0087111
T173	CHEM 6255 6262	placebo
#173	AnnotatorNotes T173	C1696465
T174	CHEM 6313 6319	Tasmar
#174	AnnotatorNotes T174	C0595276
T175	CHEM 6333 6343	inhibiteur
#175	AnnotatorNotes T175	C0003139
T176	CHEM 6350 6354	COMT
#176	AnnotatorNotes T176	C0007407
T177	CHEM 6408 6416	lévodopa
#177	AnnotatorNotes T177	C0023570
T178	LIVB 6456 6464	patients
#178	AnnotatorNotes T178	C0030705
T179	PROC 6465 6472	traités
#179	AnnotatorNotes T179	C0087111
T180	LIVB 6533 6541	patients
#180	AnnotatorNotes T180	C0030705
T181	PROC 6542 6549	traités
#181	AnnotatorNotes T181	C0087111
T182	CHEM 6762 6775	transaminases
#182	AnnotatorNotes T182	C0002594
T183	LIVB 6839 6847	patients
#183	AnnotatorNotes T183	C0030705
T184	PROC 6868 6878	traitement
#184	AnnotatorNotes T184	C0087111
T185	PROC 6908 6918	traitement
#185	AnnotatorNotes T185	C0087111
T186	CHEM 6951 6964	transaminases
#186	AnnotatorNotes T186	C0002594
T187	DISO 7019 7032	rhabdomyolyse
#187	AnnotatorNotes T187	C0035410
T188	DISO 7049 7052	SMN
#188	AnnotatorNotes T188	C0027849
T189	DISO 7062 7073	dyskinésies
#189	AnnotatorNotes T189	C0013384
T190	DISO 7112 7131	effets indésirables
#190	AnnotatorNotes T190	C0559546
T191	CHEM 7155 7161	Tasmar
#191	AnnotatorNotes T191	C0595276
T192	CHEM 7227 7234	placebo
#192	AnnotatorNotes T192	C1696465
T193	DISO 7239 7259	Douleurs thoraciques
#193	AnnotatorNotes T193	C0008031
T194	DISO 7262 7303	Infection des voies aériennes supérieures
#194	AnnotatorNotes T194	C0035243
T195	ANAT 7276 7303	voies aériennes supérieures
#195	AnnotatorNotes T195	C0458578
T196	DISO 7324 7344	surdosage accidentel
#196	AnnotatorNotes T196	C0151821
T197	CHEM 7366 7375	tolcapone
#197	AnnotatorNotes T197	C0246330
T105	PROC 7193 7212	essais de phase III
#105	AnnotatorNotes T105	C1096780
T109	DISO 7324 7333;7348 7360	surdosage intentionnel
#109	AnnotatorNotes T109	C0151821
